Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Severe allergic reactions to thiol-based cytoprotective agents mesna and amifostine in a child with a supratentorial primitive neuroectodermal tumor.

Dorris K, Fouladi M, Davies SM, Perentesis JP, Lawrence JM, Chow LM, Assa'ad A, Uygungil B, Jodele S.

J Pediatr Hematol Oncol. 2011 Aug;33(6):e250-2. doi: 10.1097/MPH.0b013e31820c3403.

PMID:
21646919
[PubMed - indexed for MEDLINE]
2.

Blood thiols following amifostine and mesna infusions, a pediatric oncology group study.

Souid AK, Fahey RC, Aktas MK, Sayin OA, Karjoo S, Newton GL, Sadowitz PD, Dubowy RL, Bernstein ML.

Drug Metab Dispos. 2001 Nov;29(11):1460-6.

PMID:
11602522
[PubMed - indexed for MEDLINE]
Free Article
3.

Adverse hypersensitivity reactions to mesna as adjunctive therapy for cyclophosphamide.

Khaw SL, Downie PA, Waters KD, Ashley DM, Heath JA.

Pediatr Blood Cancer. 2007 Sep;49(3):341-3. Review.

PMID:
16333822
[PubMed - indexed for MEDLINE]
4.

WR-2721 (amifostine) infusion in patients with Ewing's sarcoma receiving ifosfamide and cyclophosphamide with mesna: drug and thiol levels in plasma and blood cells, a Pediatric Oncology Group study.

Souid AK, Fahey RC, Dubowy RL, Newton GL, Bernstein ML.

Cancer Chemother Pharmacol. 1999;44(6):498-504.

PMID:
10550571
[PubMed - indexed for MEDLINE]
5.

Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.

Fangusaro J, Finlay J, Sposto R, Ji L, Saly M, Zacharoulis S, Asgharzadeh S, Abromowitch M, Olshefski R, Halpern S, Dubowy R, Comito M, Diez B, Kellie S, Hukin J, Rosenblum M, Dunkel I, Miller DC, Allen J, Gardner S.

Pediatr Blood Cancer. 2008 Feb;50(2):312-8.

PMID:
17668858
[PubMed - indexed for MEDLINE]
6.

Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy.

Reddy AT, Janss AJ, Phillips PC, Weiss HL, Packer RJ.

Cancer. 2000 May 1;88(9):2189-93.

PMID:
10813733
[PubMed - indexed for MEDLINE]
7.

American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.

Hensley ML, Schuchter LM, Lindley C, Meropol NJ, Cohen GI, Broder G, Gradishar WJ, Green DM, Langdon RJ Jr, Mitchell RB, Negrin R, Szatrowski TP, Thigpen JT, Von Hoff D, Wasserman TH, Winer EP, Pfister DG.

J Clin Oncol. 1999 Oct;17(10):3333-55.

PMID:
10506637
[PubMed - indexed for MEDLINE]
Free Article
8.

High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.

Butturini AM, Jacob M, Aguajo J, Vander-Walde NA, Villablanca J, Jubran R, Erdreich-Epstein A, Marachelian A, Dhall G, Finlay JL.

Cancer. 2009 Jul 1;115(13):2956-63. doi: 10.1002/cncr.24341.

PMID:
19402050
[PubMed - indexed for MEDLINE]
Free Article
9.

High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.

Sung KW, Yoo KH, Cho EJ, Koo HH, Lim do H, Shin HJ, Ahn SD, Ra YS, Choi ES, Ghim TT.

Pediatr Blood Cancer. 2007 Apr;48(4):408-15.

PMID:
17066462
[PubMed - indexed for MEDLINE]
10.

Delayed radioprotection by NFkappaB-mediated induction of Sod2 (MnSOD) in SA-NH tumor cells after exposure to clinically used thiol-containing drugs.

Murley JS, Kataoka Y, Cao D, Li JJ, Oberley LW, Grdina DJ.

Radiat Res. 2004 Nov;162(5):536-46.

PMID:
15624308
[PubMed - indexed for MEDLINE]
11.

Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.

Massimino M, Gandola L, Spreafico F, Luksch R, Collini P, Giangaspero F, Simonetti F, Casanova M, Cefalo G, Pignoli E, Ferrari A, Terenziani M, Podda M, Meazza C, Polastri D, Poggi G, Ravagnani F, Fossati-Bellani F.

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1031-7. Epub 2005 Dec 15.

PMID:
16343801
[PubMed - indexed for MEDLINE]
12.

Late complete remission of supratentorial primitive neuroectodermal tumor (CNS-PNET) after multiple relapses.

von Bueren AO, Warmuth-Metz M, Schlegel PG, Soerensen N, Krauss J, Roggendorf W, Pietsch T, Feiden W, Graf N, Pohl F, Flentje M, Kuehl J, Rutkowski S.

Pediatr Blood Cancer. 2011 Mar;56(3):503-5. doi: 10.1002/pbc.22914. No abstract available.

PMID:
21113945
[PubMed - indexed for MEDLINE]
13.

Prognostic factors in children with supratentorial (nonpineal) primitive neuroectodermal tumors. A neurosurgical perspective from the Children's Cancer Group.

Albright AL, Wisoff JH, Zeltzer P, Boyett J, Rorke LB, Stanley P, Geyer JR, Milstein JM.

Pediatr Neurosurg. 1995;22(1):1-7.

PMID:
7888387
[PubMed - indexed for MEDLINE]
14.

Supratentorial primitive neuroectodermal tumors in young children.

Larouche V, Capra M, Huang A, Bartels U, Bouffet E.

J Clin Oncol. 2006 Dec 10;24(35):5609; author reply 5609-10. No abstract available.

PMID:
17158547
[PubMed - indexed for MEDLINE]
Free Article
15.

A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET.

Chintagumpala M, Hassall T, Palmer S, Ashley D, Wallace D, Kasow K, Merchant TE, Krasin MJ, Dauser R, Boop F, Krance R, Woo S, Cheuk R, Lau C, Gilbertson R, Gajjar A.

Neuro Oncol. 2009 Feb;11(1):33-40. doi: 10.1215/15228517-2008-079. Epub 2008 Sep 16.

PMID:
18796696
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Patterns of failure in supratentorial primitive neuroectodermal tumors treated in Children's Cancer Group Study 921, a phase III combined modality study.

Hong TS, Mehta MP, Boyett JM, Donahue B, Rorke LB, Yao MS, Zeltzer PM.

Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):204-13.

PMID:
15337557
[PubMed - indexed for MEDLINE]
17.

A novel splice mutation in the TP53 gene associated with Leydig cell tumor and primitive neuroectodermal tumor.

Stecher CW, Grønbaek K, Hasle H.

Pediatr Blood Cancer. 2008 Mar;50(3):701-3.

PMID:
17066464
[PubMed - indexed for MEDLINE]
18.

Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?

Biswas S, Burke A, Cherian S, Williams D, Nicholson J, Horan G, Jefferies S, Williams M, Earl HM, Burnet NG, Hatcher H.

Pediatr Blood Cancer. 2009 Jul;52(7):796-803. doi: 10.1002/pbc.21899.

PMID:
19202566
[PubMed - indexed for MEDLINE]
19.

Pineal and nonpineal supratentorial primitive neuroectodermal tumors.

Jakacki RI.

Childs Nerv Syst. 1999 Oct;15(10):586-91. Review.

PMID:
10550590
[PubMed - indexed for MEDLINE]
20.

Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.

Strother D, Ashley D, Kellie SJ, Patel A, Jones-Wallace D, Thompson S, Heideman R, Benaim E, Krance R, Bowman L, Gajjar A.

J Clin Oncol. 2001 May 15;19(10):2696-704.

PMID:
11352962
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk